Cargando…

Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis

BACKGROUND: The CAnadian REgistry for Pulmonary Fibrosis (CARE-PF) is a multi-center, prospective registry designed to study the natural history of fibrotic interstitial lung disease (ILD) in adults. The aim of this cross-sectional sub-study was to describe the baseline characteristics, risk factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Fisher, J. H., Kolb, M., Algamdi, M., Morisset, J., Johannson, K. A., Shapera, S., Wilcox, P., To, T., Sadatsafavi, M., Manganas, H., Khalil, N., Hambly, N., Halayko, A. J., Gershon, A. S., Fell, C. D., Cox, G., Ryerson, C. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880596/
https://www.ncbi.nlm.nih.gov/pubmed/31771541
http://dx.doi.org/10.1186/s12890-019-0986-4
_version_ 1783473793687093248
author Fisher, J. H.
Kolb, M.
Algamdi, M.
Morisset, J.
Johannson, K. A.
Shapera, S.
Wilcox, P.
To, T.
Sadatsafavi, M.
Manganas, H.
Khalil, N.
Hambly, N.
Halayko, A. J.
Gershon, A. S.
Fell, C. D.
Cox, G.
Ryerson, C. J.
author_facet Fisher, J. H.
Kolb, M.
Algamdi, M.
Morisset, J.
Johannson, K. A.
Shapera, S.
Wilcox, P.
To, T.
Sadatsafavi, M.
Manganas, H.
Khalil, N.
Hambly, N.
Halayko, A. J.
Gershon, A. S.
Fell, C. D.
Cox, G.
Ryerson, C. J.
author_sort Fisher, J. H.
collection PubMed
description BACKGROUND: The CAnadian REgistry for Pulmonary Fibrosis (CARE-PF) is a multi-center, prospective registry designed to study the natural history of fibrotic interstitial lung disease (ILD) in adults. The aim of this cross-sectional sub-study was to describe the baseline characteristics, risk factors, and comorbidities of patients enrolled in CARE-PF to date. METHODS: Patients completed study questionnaires and clinical measurements at enrollment and each follow-up visit. Environmental exposures were assessed by patient self-report and comorbidities by the Charlson Comorbidity Index (CCI). Baseline characteristics, exposures, and comorbidities were described for the overall study population and for incident cases, and were compared across ILD subtypes. RESULTS: The full cohort included 1285 patients with ILD (961 incident cases (74.8%)). Diagnoses included connective tissue disease-associated ILD (33.3%), idiopathic pulmonary fibrosis (IPF) (24.7%), unclassifiable ILD (22.3%), chronic hypersensitivity pneumonitis (HP) (7.5%), sarcoidosis (3.2%), non-IPF idiopathic interstitial pneumonias (3.0%, including idiopathic nonspecific interstitial pneumonia (NSIP) in 0.9%), and other ILDs (6.0%). Patient-reported exposures were most frequent amongst chronic HP, but common across all ILD subtypes. The CCI was ≤2 in 81% of patients, with a narrow distribution and range of values. CONCLUSIONS: CTD-ILD, IPF, and unclassifiable ILD made up 80% of ILD diagnoses at ILD referral centers in Canada, while idiopathic NSIP was rare when adhering to recommended diagnostic criteria. CCI had a very narrow distribution across our cohort suggesting it may be a poor discriminator in assessing the impact of comorbidities on patients with ILD.
format Online
Article
Text
id pubmed-6880596
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68805962019-12-03 Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis Fisher, J. H. Kolb, M. Algamdi, M. Morisset, J. Johannson, K. A. Shapera, S. Wilcox, P. To, T. Sadatsafavi, M. Manganas, H. Khalil, N. Hambly, N. Halayko, A. J. Gershon, A. S. Fell, C. D. Cox, G. Ryerson, C. J. BMC Pulm Med Research Article BACKGROUND: The CAnadian REgistry for Pulmonary Fibrosis (CARE-PF) is a multi-center, prospective registry designed to study the natural history of fibrotic interstitial lung disease (ILD) in adults. The aim of this cross-sectional sub-study was to describe the baseline characteristics, risk factors, and comorbidities of patients enrolled in CARE-PF to date. METHODS: Patients completed study questionnaires and clinical measurements at enrollment and each follow-up visit. Environmental exposures were assessed by patient self-report and comorbidities by the Charlson Comorbidity Index (CCI). Baseline characteristics, exposures, and comorbidities were described for the overall study population and for incident cases, and were compared across ILD subtypes. RESULTS: The full cohort included 1285 patients with ILD (961 incident cases (74.8%)). Diagnoses included connective tissue disease-associated ILD (33.3%), idiopathic pulmonary fibrosis (IPF) (24.7%), unclassifiable ILD (22.3%), chronic hypersensitivity pneumonitis (HP) (7.5%), sarcoidosis (3.2%), non-IPF idiopathic interstitial pneumonias (3.0%, including idiopathic nonspecific interstitial pneumonia (NSIP) in 0.9%), and other ILDs (6.0%). Patient-reported exposures were most frequent amongst chronic HP, but common across all ILD subtypes. The CCI was ≤2 in 81% of patients, with a narrow distribution and range of values. CONCLUSIONS: CTD-ILD, IPF, and unclassifiable ILD made up 80% of ILD diagnoses at ILD referral centers in Canada, while idiopathic NSIP was rare when adhering to recommended diagnostic criteria. CCI had a very narrow distribution across our cohort suggesting it may be a poor discriminator in assessing the impact of comorbidities on patients with ILD. BioMed Central 2019-11-27 /pmc/articles/PMC6880596/ /pubmed/31771541 http://dx.doi.org/10.1186/s12890-019-0986-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Fisher, J. H.
Kolb, M.
Algamdi, M.
Morisset, J.
Johannson, K. A.
Shapera, S.
Wilcox, P.
To, T.
Sadatsafavi, M.
Manganas, H.
Khalil, N.
Hambly, N.
Halayko, A. J.
Gershon, A. S.
Fell, C. D.
Cox, G.
Ryerson, C. J.
Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis
title Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis
title_full Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis
title_fullStr Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis
title_full_unstemmed Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis
title_short Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis
title_sort baseline characteristics and comorbidities in the canadian registry for pulmonary fibrosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880596/
https://www.ncbi.nlm.nih.gov/pubmed/31771541
http://dx.doi.org/10.1186/s12890-019-0986-4
work_keys_str_mv AT fisherjh baselinecharacteristicsandcomorbiditiesinthecanadianregistryforpulmonaryfibrosis
AT kolbm baselinecharacteristicsandcomorbiditiesinthecanadianregistryforpulmonaryfibrosis
AT algamdim baselinecharacteristicsandcomorbiditiesinthecanadianregistryforpulmonaryfibrosis
AT morissetj baselinecharacteristicsandcomorbiditiesinthecanadianregistryforpulmonaryfibrosis
AT johannsonka baselinecharacteristicsandcomorbiditiesinthecanadianregistryforpulmonaryfibrosis
AT shaperas baselinecharacteristicsandcomorbiditiesinthecanadianregistryforpulmonaryfibrosis
AT wilcoxp baselinecharacteristicsandcomorbiditiesinthecanadianregistryforpulmonaryfibrosis
AT tot baselinecharacteristicsandcomorbiditiesinthecanadianregistryforpulmonaryfibrosis
AT sadatsafavim baselinecharacteristicsandcomorbiditiesinthecanadianregistryforpulmonaryfibrosis
AT manganash baselinecharacteristicsandcomorbiditiesinthecanadianregistryforpulmonaryfibrosis
AT khaliln baselinecharacteristicsandcomorbiditiesinthecanadianregistryforpulmonaryfibrosis
AT hamblyn baselinecharacteristicsandcomorbiditiesinthecanadianregistryforpulmonaryfibrosis
AT halaykoaj baselinecharacteristicsandcomorbiditiesinthecanadianregistryforpulmonaryfibrosis
AT gershonas baselinecharacteristicsandcomorbiditiesinthecanadianregistryforpulmonaryfibrosis
AT fellcd baselinecharacteristicsandcomorbiditiesinthecanadianregistryforpulmonaryfibrosis
AT coxg baselinecharacteristicsandcomorbiditiesinthecanadianregistryforpulmonaryfibrosis
AT ryersoncj baselinecharacteristicsandcomorbiditiesinthecanadianregistryforpulmonaryfibrosis